According to Cognitive Market Research, the global Transcriptomics market size is USD 5984.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 7.90% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 2393.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1795.26 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1376.37 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 299.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 119.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
Drug Discovery held the highest Transcriptomics market revenue share in 2024.
